REG - Animalcare Group PLC - Total Voting Rights

AnimalcareAnnouncement

01/07/2021 07:00

RNS Number : 7393D
  
Animalcare Group PLC
  
01 July 2021
  
 

 
ANIMALCARE GROUP PLC
 
 ("Animalcare" or the "Company" or the "Group")
 
Total Voting Rights
 
1 July 2021. In accordance with the FCA's Disclosure and Transparency Rules, Animalcare Group plc (AIM: ANCR) wishes to notify the market of the following: 
As at 30 June 2021, the Company's issued share capital consisted of 60,077,161 ordinary shares of 20p each ("Ordinary Shares"), all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as at 30 June 2021 is therefore 60,077,161.
The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.
Enquiries:



Animalcare Group plc


 




Chris Brewster, Chief Financial Officer and Company Secretary


+44 (0)1904 487 687 
communications@animalcaregroup.com
 




Stifel Nicolaus Europe Limited
(Nominated Adviser & Joint Broker)


+44 (0)20 7710 7600




Ben Maddison
Fred Walsh
Nick Adams








Panmure Gordon
(Joint Broker)


+44 (0)20 7886 2500




Corporate Finance:
Freddy Crossley/Emma Earl
 
Corporate Broking:
Rupert Dearden
 







About Animalcare www.animalcaregroup.com
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TVREAKKEDSKFEFA